Evidence map›Paper›PMID 27905431›Full record

ArticleNature2016

The SND proteins constitute an alternative targeting route to the endoplasmic reticulum.

Naama Aviram, Tslil Ast, Elizabeth A Costa, Eric C Arakel, Silvia G Chuartzman, Calvin H Jan, Sarah Haßdenteufel, Johanna Dudek, Martin Jung, Stefan Schorr and 4 more

Abstract read
In one paragraph

Article in Nature, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 128 papers.

0numbers the graph read from it
0cells of the map it votes in
128citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

128 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. GET3 regulates apoptosis via tail-anchoring of MCL1.Cell death and differentiation · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. YeastbioRxiv : the preprint server for biology · 2025
    Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review

68 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Naama AviramDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.
Tslil AstDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.
Elizabeth A CostaDepartment of Cellular and Molecular Pharmacology, UCSF California Institute for Quantitative Biomedical Research and Howard Hughes Medical Institute, San Francisco, California 94158-2330, USA.
Eric C ArakelDepartment of Molecular Biology, University Medical Center Göttingen, 37073 Göttingen, Germany.
Silvia G ChuartzmanDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.
Calvin H JanDepartment of Cellular and Molecular Pharmacology, UCSF California Institute for Quantitative Biomedical Research and Howard Hughes Medical Institute, San Francisco, California 94158-2330, USA.
Sarah HaßdenteufelDepartment of Medical Biochemistry and Molecular Biology, Saarland University, 66421 Homburg, Germany.
Johanna DudekDepartment of Medical Biochemistry and Molecular Biology, Saarland University, 66421 Homburg, Germany.
Martin JungDepartment of Medical Biochemistry and Molecular Biology, Saarland University, 66421 Homburg, Germany.
Stefan SchorrDepartment of Medical Biochemistry and Molecular Biology, Saarland University, 66421 Homburg, Germany.
Richard ZimmermannDepartment of Medical Biochemistry and Molecular Biology, Saarland University, 66421 Homburg, Germany.
Blanche SchwappachDepartment of Molecular Biology, University Medical Center Göttingen, 37073 Göttingen, Germany.
Jonathan S WeissmanDepartment of Cellular and Molecular Pharmacology, UCSF California Institute for Quantitative Biomedical Research and Howard Hughes Medical Institute, San Francisco, California 94158-2330, USA.
Maya SchuldinerDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.

Funding

GENETICS OF EUCARYOTIC AND PROCARYOTIC ORGANISMST32GM007810 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ASHRAFI, KAVEH, NARLIKAR, GEETA J · 1985 to 2020
$15.1M
PROJECT 3P50GM102706 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI CATE, JAMIE H · 2012 to 2016
$9.5M
Howard Hughes Medical InstituteNIGMS NIH HHS P50 GM102706NIGMS NIH HHS T32 GM007810
6 · The paper itself

Abstract

In eukaryotes, up to one-third of cellular proteins are targeted to the endoplasmic reticulum, where they undergo folding, processing, sorting and trafficking to subsequent endomembrane compartments. Targeting to the endoplasmic reticulum has been shown to occur co-translationally by the signal recognition particle (SRP) pathway or post-translationally by the mammalian transmembrane recognition complex of 40 kDa (TRC40) and homologous yeast guided entry of tail-anchored proteins (GET) pathways. Despite the range of proteins that can be catered for by these two pathways, many proteins are still known to be independent of both SRP and GET, so there seems to be a critical need for an additional dedicated pathway for endoplasmic reticulum relay. We set out to uncover additional targeting proteins using unbiased high-content screening approaches. To this end, we performed a systematic visual screen using the yeast Saccharomyces cerevisiae, and uncovered three uncharacterized proteins whose loss affected targeting. We suggest that these proteins work together and demonstrate that they function in parallel with SRP and GET to target a broad range of substrates to the endoplasmic reticulum. The three proteins, which we name Snd1, Snd2 and Snd3 (for SRP-independent targeting), can synthetically compensate for the loss of both the SRP and GET pathways, and act as a backup targeting system. This explains why it has previously been difficult to demonstrate complete loss of targeting for some substrates. Our discovery thus puts in place an essential piece of the endoplasmic reticulum targeting puzzle, highlighting how the targeting apparatus of the eukaryotic cell is robust, interlinked and flexible.

Indexed as

Endoplasmic ReticulumHEK293 CellsHumansMembrane ProteinsPhosphate Transport ProteinsProtein DomainsProtein Sorting SignalsProtein TransportRibosomal ProteinsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSignal Recognition ParticleMembrane ProteinsPHO88 protein, S cerevisiaePhosphate Transport ProteinsProtein Sorting SignalsRibosomal ProteinsSaccharomyces cerevisiae ProteinsSignal Recognition ParticleSnd1 protein, S cerevisiaeSnd2 protein, S cerevisiae

Identifiers

PMID27905431
PMCPMC5513701

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.